Novavax | NVAX - Créances Commerciales





Créances Commerciales Changement Date
Adma Biologics USD 135.86M 22.57M 2026-03
Agenus USD 22.34M 107K 2026-03
AstraZeneca USD 18.86B 972M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
Cassava Sciences USD 117K 3K 2026-03
Geron USD 44.1M 4.87M 2026-03
GlaxoSmithKline GBP 8.07B 137M 2026-06
MannKind USD 43.21M 15.07M 2026-06
Merck USD 12.21B 435M 2026-03
Moderna USD 17M 54M 2026-06
Novartis USD 9.6B 2.69B 2026-03
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 16.19B 19M 2026-06
Sanofi EUR 492M 10M 2026-06
Sarepta Therapeutics USD 393.8M 154.11M 2026-06
TG Therapeutics USD 401.56M 9.52M 2026-06